794 related articles for article (PubMed ID: 18948693)
1. Rett syndrome: from the gene to the disease.
Matijevic T; Knezevic J; Slavica M; Pavelic J
Eur Neurol; 2009; 61(1):3-10. PubMed ID: 18948693
[TBL] [Abstract][Full Text] [Related]
2. Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients: a molecular update.
Philippe C; Villard L; De Roux N; Raynaud M; Bonnefond JP; Pasquier L; Lesca G; Mancini J; Jonveaux P; Moncla A; Chelly J; Bienvenu T
Eur J Med Genet; 2006; 49(1):9-18. PubMed ID: 16473305
[TBL] [Abstract][Full Text] [Related]
3. The MECP2 gene mutation screening in Rett syndrome patients from Croatia.
Matijević T; Knezević J; Barisić I; Resić B; Culić V; Pavelić J
Ann N Y Acad Sci; 2006 Dec; 1091():225-32. PubMed ID: 17341617
[TBL] [Abstract][Full Text] [Related]
4. Clinical profiles of four patients with Rett syndrome carrying a novel exon 1 mutation or genomic rearrangement in the MECP2 gene.
Bartholdi D; Klein A; Weissert M; Koenig N; Baumer A; Boltshauser E; Schinzel A; Berger W; Mátyás G
Clin Genet; 2006 Apr; 69(4):319-26. PubMed ID: 16630165
[TBL] [Abstract][Full Text] [Related]
5. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype.
Hoffbuhr KC; Moses LM; Jerdonek MA; Naidu S; Hoffman EP
Ment Retard Dev Disabil Res Rev; 2002; 8(2):99-105. PubMed ID: 12112735
[TBL] [Abstract][Full Text] [Related]
6. MeCP2 dysfunction in Rett syndrome and related disorders.
Moretti P; Zoghbi HY
Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
[TBL] [Abstract][Full Text] [Related]
7. MECP2 mutations in Serbian Rett syndrome patients.
Djarmati A; Dobricić V; Kecmanović M; Marsh P; Jancić-Stefanović J; Klein C; Djurić M; Romac S
Acta Neurol Scand; 2007 Dec; 116(6):413-9. PubMed ID: 17986102
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of Japanese patients with Rett syndrome: Identification of five novel mutations and genotype-phenotype correlation.
Yamada Y; Miura K; Kumagai T; Hayakawa C; Miyazaki S; Matsumoto A; Kurosawa K; Nomura N; Taniguchi H; Sonta SI; Yamanaka T; Wakamatsu N
Hum Mutat; 2001 Sep; 18(3):253. PubMed ID: 11524741
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome.
Amano K; Nomura Y; Segawa M; Yamakawa K
J Hum Genet; 2000; 45(4):231-6. PubMed ID: 10944854
[TBL] [Abstract][Full Text] [Related]
10. X chromosome inactivation in Rett Syndrome and its correlations with MECP2 mutations and phenotype.
Xinhua Bao ; Shengling Jiang ; Fuying Song ; Hong Pan ; Meirong Li ; Wu XR
J Child Neurol; 2008 Jan; 23(1):22-5. PubMed ID: 18184939
[TBL] [Abstract][Full Text] [Related]
11. MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders.
Psoni S; Sofocleous C; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Fryssira-Kanioura H
Brain Dev; 2012 Jun; 34(6):487-95. PubMed ID: 21982064
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of MECP2 mutations in New Zealand Rett syndrome patients.
Raizis AM; Saleem M; MacKay R; George PM
N Z Med J; 2009 Jun; 122(1296):21-8. PubMed ID: 19652677
[TBL] [Abstract][Full Text] [Related]
13. Parental origin of de novo MECP2 mutations in Rett syndrome.
Girard M; Couvert P; Carrié A; Tardieu M; Chelly J; Beldjord C; Bienvenu T
Eur J Hum Genet; 2001 Mar; 9(3):231-6. PubMed ID: 11313764
[TBL] [Abstract][Full Text] [Related]
14. Mutations and polymorphisms in the human methyl CpG-binding protein MECP2.
Miltenberger-Miltenyi G; Laccone F
Hum Mutat; 2003 Aug; 22(2):107-15. PubMed ID: 12872250
[TBL] [Abstract][Full Text] [Related]
15. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice.
Gemelli T; Berton O; Nelson ED; Perrotti LI; Jaenisch R; Monteggia LM
Biol Psychiatry; 2006 Mar; 59(5):468-76. PubMed ID: 16199017
[TBL] [Abstract][Full Text] [Related]
16. Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms.
Fukuda T; Yamashita Y; Nagamitsu S; Miyamoto K; Jin JJ; Ohmori I; Ohtsuka Y; Kuwajima K; Endo S; Iwai T; Yamagata H; Tabara Y; Miki T; Matsuishi T; Kondo I
Brain Dev; 2005 Apr; 27(3):211-7. PubMed ID: 15737703
[TBL] [Abstract][Full Text] [Related]
17. Deleterious mutations in exon 1 of MECP2 in Rett syndrome.
Quenard A; Yilmaz S; Fontaine H; Bienvenu T; Moncla A; des Portes V; Rivier F; Mathieu M; Raux G; Jonveaux P; Philippe C
Eur J Med Genet; 2006; 49(4):313-22. PubMed ID: 16829352
[TBL] [Abstract][Full Text] [Related]
18. The story of Rett syndrome: from clinic to neurobiology.
Chahrour M; Zoghbi HY
Neuron; 2007 Nov; 56(3):422-37. PubMed ID: 17988628
[TBL] [Abstract][Full Text] [Related]
19. [Rett syndrome: clinical and molecular aspects].
Záhoráková D; Zeman J; Martásek P
Cas Lek Cesk; 2007; 146(8):647-52. PubMed ID: 17874730
[TBL] [Abstract][Full Text] [Related]
20. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
